• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大疱性类天疱疮患者皮肤病变及血液中的调节性T细胞。

Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid.

作者信息

Antiga E, Quaglino P, Volpi W, Pierini I, Del Bianco E, Bianchi B, Novelli M, Savoia P, Bernengo M G, Fabbri P, Caproni M

机构信息

Department of Critical Care, Section of Dermatology, University of Florence, Florence, Italy.

Department of Medical Sciences, 1 st Dermatologic Clinic, University of Turin, Turin, Italy.

出版信息

J Eur Acad Dermatol Venereol. 2014 Feb;28(2):222-30. doi: 10.1111/jdv.12091. Epub 2013 Jan 18.

DOI:10.1111/jdv.12091
PMID:23331964
Abstract

BACKGROUND

Although regulatory T cells (Tregs) are affected in several autoimmune skin diseases, only two studies have been performed in patients with bullous pemphigoid (BP) with contrasting results.

OBJECTIVE

To characterize Tregs and to determine the serum levels of regulatory cytokines in patients with BP.

METHODS

In BP lesional skin, immunohistochemistry and confocal microscopy were performed for CD4(+) , CD25(+) , forkhead/winged helix transcription factor (FOXP3)(+) , transforming growth factor (TGF)-β(+) and interleukin (IL)-10(+) cells. In addition, the number of CD4(+) CD25(++) FOXP3(+) Tregs in peripheral blood was assessed by flow cytometry, and the levels of TGF-β and IL-10 were determined in serum samples by enzyme-linked immunosorbent assay before and after steroid therapy. Controls included patients with psoriasis, atopic dermatitis (AD) and healthy donors.

RESULTS

The frequency of FOXP3(+) cells was significantly reduced in skin lesions from patients with BP (P < 0.001) compared with psoriasis and AD. Moreover, the number of IL-10(+) cells was lower in BP than in psoriasis (P < 0.001) and AD (P = 0.002), while no differences were observed in the number of TGF-β(+) cells. CD4(+) CD25(++) FOXP3(+) Treg in the peripheral blood of patients with BP was significantly reduced compared with healthy controls (P < 0.001), and augmented significantly after steroid therapy (P = 0.001). Finally, TGF-β and IL-10 serum levels were similar in patients with BP compared with healthy controls. However, after therapy, BP patients showed significantly higher IL-10 serum levels than before therapy (P = 0.01).

CONCLUSIONS

These data suggest that the depletion of Tregs and of IL-10 in patients with BP may be an important factor in the pathogenesis of the disease.

摘要

背景

尽管调节性T细胞(Tregs)在几种自身免疫性皮肤病中受到影响,但仅有两项针对大疱性类天疱疮(BP)患者的研究,结果却相互矛盾。

目的

对BP患者的Tregs进行特征分析,并测定其调节性细胞因子的血清水平。

方法

对BP患者的皮损进行免疫组织化学和共聚焦显微镜检查,检测CD4(+)、CD25(+)、叉头/翼状螺旋转录因子(FOXP3)(+)、转化生长因子(TGF)-β(+)和白细胞介素(IL)-10(+)细胞。此外,通过流式细胞术评估外周血中CD4(+) CD25(++) FOXP3(+) Tregs的数量,并在类固醇治疗前后通过酶联免疫吸附测定法测定血清样本中TGF-β和IL-10的水平。对照组包括银屑病患者、特应性皮炎(AD)患者和健康供者。

结果

与银屑病和AD相比,BP患者皮肤病变中FOXP3(+)细胞的频率显著降低(P < 0.001)。此外,BP患者中IL-10(+)细胞的数量低于银屑病患者(P < 0.001)和AD患者(P = 0.002),而TGF-β(+)细胞的数量未观察到差异。与健康对照组相比,BP患者外周血中CD4(+) CD25(++) FOXP3(+) Treg显著减少(P < 0.001),类固醇治疗后显著增加(P = 0.001)。最后,与健康对照组相比,BP患者的TGF-β和IL-10血清水平相似。然而,治疗后,BP患者的IL-10血清水平显著高于治疗前(P = 0.01)。

结论

这些数据表明,BP患者中Tregs和IL-10的耗竭可能是该疾病发病机制中的一个重要因素。

相似文献

1
Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid.大疱性类天疱疮患者皮肤病变及血液中的调节性T细胞。
J Eur Acad Dermatol Venereol. 2014 Feb;28(2):222-30. doi: 10.1111/jdv.12091. Epub 2013 Jan 18.
2
Characterization of regulatory T cells in patients with dermatomyositis.特发性炎性肌病患者调节性 T 细胞的特征。
J Autoimmun. 2010 Dec;35(4):342-50. doi: 10.1016/j.jaut.2010.07.006. Epub 2010 Sep 16.
3
Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea.系统性硬皮病和硬斑病患者皮肤损伤和血液中的调节性 T 细胞。
Br J Dermatol. 2010 May;162(5):1056-63. doi: 10.1111/j.1365-2133.2010.09633.x. Epub 2010 Jan 22.
4
Circulating level of CD4+ CD25+ FOXP3+ T cells in patients with chronic urticaria.慢性荨麻疹患者循环中CD4+ CD25+ FOXP3+ T细胞水平
Int J Dermatol. 2014 Dec;53(12):e561-6. doi: 10.1111/ijd.12630. Epub 2014 Oct 14.
5
Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis.在疱疹样皮炎患者的皮肤中,调节性 T 细胞和白细胞介素 10 减少。
J Dermatol Sci. 2015 Jan;77(1):54-62. doi: 10.1016/j.jdermsci.2014.11.003. Epub 2014 Nov 18.
6
Skin-infiltrating T cells and cytokine expression in Icelandic horses affected with insect bite hypersensitivity: a possible role for regulatory T cells.患有昆虫叮咬超敏反应的冰岛马的皮肤浸润性T细胞和细胞因子表达:调节性T细胞的可能作用
Vet Immunol Immunopathol. 2011 Mar 15;140(1-2):63-74. doi: 10.1016/j.vetimm.2010.11.016. Epub 2010 Dec 1.
7
Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus.皮肤型红斑狼疮患者皮肤损伤中调节性T细胞数量较少。
Arthritis Rheum. 2007 Jun;56(6):1910-20. doi: 10.1002/art.22699.
8
Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines.麻风病患者血清中的Th17细胞因子:与循环CD4(+) CD25(高表达)FoxP3(+)调节性T细胞以及下调细胞因子的相关性
Arch Dermatol Res. 2014 Nov;306(9):793-801. doi: 10.1007/s00403-014-1486-2. Epub 2014 Jul 14.
9
The Imbalance of Th17 cells and CD4(+) CD25(high) Foxp3(+) Treg cells in patients with atopic dermatitis.特应性皮炎患者中Th17细胞与CD4(+)CD25(高表达)Foxp3(+)调节性T细胞的失衡
J Eur Acad Dermatol Venereol. 2014 Aug;28(8):1079-86. doi: 10.1111/jdv.12288. Epub 2013 Nov 7.
10
Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid.大疱性类天疱疮中CD4+CD25+FOXP3+调节性T细胞的频率、功能及CLA表达
Exp Dermatol. 2007 Jan;16(1):13-21. doi: 10.1111/j.1600-0625.2006.00522.x.

引用本文的文献

1
Immunophenotypic and Transcriptomic Analysis of Peripheral Blood Mononuclear Cells in Bullous Pemphigoid.大疱性类天疱疮外周血单个核细胞的免疫表型和转录组分析
Ann Dermatol. 2025 Aug;37(4):191-200. doi: 10.5021/ad.25.032.
2
JAK-STAT pathway, type I/II cytokines, and new potential therapeutic strategy for autoimmune bullous diseases: update on pemphigus vulgaris and bullous pemphigoid.JAK-STAT信号通路、I/II型细胞因子与自身免疫性大疱性疾病的新潜在治疗策略:寻常型天疱疮和大疱性类天疱疮的最新进展
Front Immunol. 2025 Apr 8;16:1563286. doi: 10.3389/fimmu.2025.1563286. eCollection 2025.
3
Case report: Low-dose interleukin-2: a treatment of bullous pemphigoid with predominantly perifollicular blistering caused by PD-1/PD-L1 inhibitor.
病例报告:低剂量白细胞介素-2:一种治疗由PD-1/PD-L1抑制剂引起的以毛囊周围水疱为主的大疱性类天疱疮的方法。
Front Immunol. 2024 Dec 10;15:1496413. doi: 10.3389/fimmu.2024.1496413. eCollection 2024.
4
Study of cytokine-induced immunity in bullous pemphigoid: recent developments.大疱性类天疱疮细胞因子诱导免疫研究:最新进展。
Ann Med. 2023;55(2):2280991. doi: 10.1080/07853890.2023.2280991. Epub 2023 Dec 18.
5
From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid.从药物相关性大疱性表皮松解症的分子见解到临床观点。
Int J Mol Sci. 2023 Nov 26;24(23):16786. doi: 10.3390/ijms242316786.
6
Understanding CD4 T cells in autoimmune bullous diseases.了解自身免疫性大疱性疾病中的 CD4 T 细胞。
Front Immunol. 2023 Apr 17;14:1161927. doi: 10.3389/fimmu.2023.1161927. eCollection 2023.
7
Adaptive and innate immune pathogenesis of bullous pemphigoid: A review.大疱性类天疱疮的适应性和固有免疫发病机制:综述。
Front Immunol. 2023 Mar 10;14:1144429. doi: 10.3389/fimmu.2023.1144429. eCollection 2023.
8
The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets.大疱性类天疱疮的细胞因子环境:当前及新的治疗靶点
Front Med (Lausanne). 2023 Feb 6;10:1128154. doi: 10.3389/fmed.2023.1128154. eCollection 2023.
9
What's new in the pathogeneses and triggering factors of bullous pemphigoid.大疱性类天疱疮发病机制和诱发因素的新进展。
J Dermatol. 2023 Feb;50(2):140-149. doi: 10.1111/1346-8138.16654. Epub 2022 Nov 22.
10
Cytokine-Mediated Crosstalk Between Keratinocytes and T Cells in Atopic Dermatitis.细胞因子介导的特应性皮炎中角质形成细胞与 T 细胞的串扰。
Front Immunol. 2022 Apr 7;13:801579. doi: 10.3389/fimmu.2022.801579. eCollection 2022.